Smallpox drugmakers rise as U.S. declares monkeypox 'public health emergency'

Chimerix

04/08/2022 20:06

** Makers of smallpox drugs rise as the United States has
declared the monkeypox outbreak a "public health emergency"
 urn:newsml:reuters.com:*:nL1N2ZG1WB
    ** Shares of Siga Technologies  SIGA.O , which makes
smallpox treatment tecovirimat or TPOXX, rise 8.7% to $19.88
    ** Chimerix shares  CMRX.O  surge 17.2% to $2.73
    ** CMRX makes smallpox drug Tembexa and is in the process of
selling the rights for the drug to Emergent BioSolutions  EBS.N 
    ** EBS is up 6% at $32.57
    ** Shares of monkeypox vaccine developer GeoVax Labs
 GOVX.O  soar 35% to $3.70
    ** Shares in Tonix Pharma  TNXP.O , whose website shows it
has a smallpox vaccine in clinical testing, up 6.2% at $1.88
    ** Monkeypox is a viral infection that causes symptoms
similar to, but milder than, smallpox
    ** The World Health Organization (WHO) has also declared
monkeypox a "public health emergency of international concern",
its highest alert level

 (Reporting by Praveen Paramasivam)
 ((Praveen.Paramasivam@thomsonreuters.com;))